Kaplan-Meier survival curves for the 59 patients with deletions compared with the 280 patients without deletions. (A) Overall survival, (B) survival censored at the time of switch to imatinib or allogeneic stem cell transplantation in the first chronic phase, (C) survival after allogeneic stem cell transplantation in the first chronic phase.